0
0
0
0
1
2
3
$0
Is Zscaler solid or fragile? The Finex Financial Health Scanner reads ZS's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $3.4B |
|---|---|
| Net income | -$63.2M |
| Operating margin | -4.0% |
| Net margin | -1.9% |
| Cash and investments | $3.5B |
| Total debt | $1.7B |
| Free cash flow | $1.1B |
| Revenue growth (1 year) | 25.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.